Intero Biosystems
PrivateLast Round
Pre Seed
Jun 11, 2025
Total Funding Raised
$2.93M
Company Overview
Intero Biosystems is a biotechnology company spun out of the University of Michigan in 2024 that develops advanced human intestinal organoids for preclinical drug testing. Its flagship product, GastroScreen, is a stem cell-derived "mini-gut" in a dish that replicates the human intestine, including supporting tissues like muscle, blood vessels, and neurons. The platform is designed to provide pharmaceutical companies with a more accurate, predictive, and ethical model for safety and efficacy testing, aiming to reduce the high failure rate of drugs in clinical trials and decrease reliance on animal models. The company raised an oversubscribed $2 million pre-seed round in June 2025.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Intero Biosystems Comps
Public and private peers based on sector, stage, and business model.
Intero Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jun 11, 2025 | ||||
| Grant | Apr 12, 2025 | ||||
| Grant | Oct 10, 2024 | ||||
| Grant | Apr 26, 2024 |
Intero Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bronco Venture Fund | Pre Seed |
| GOOSE Capital | Pre Seed, Grant |
| nCourage Investment Group | Pre Seed |
| Michigan Rise | Pre Seed |
| Michigan Biomedical Venture Fund | Pre Seed |
| Kalamazoo Forward Ventures | Pre Seed |
| Houston Angel Network | Pre Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2025
Attended the 2025 Rice Business Plan Competition on April 15, 2025.
- Apr 15, 2025
Won grand prize at the 2025 Rice Business Plan Competition.
Intero Biosystems Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Intero Biosystems's valuation, stock price, and market status.
